Cargando…
AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165399/ https://www.ncbi.nlm.nih.gov/pubmed/33431021 http://dx.doi.org/10.1186/s13321-020-00429-4 |
_version_ | 1783523469571391488 |
---|---|
author | Spiegel, Jacob O. Durrant, Jacob D. |
author_facet | Spiegel, Jacob O. Durrant, Jacob D. |
author_sort | Spiegel, Jacob O. |
collection | PubMed |
description | We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from http://durrantlab.com/autogrow4. [Image: see text] |
format | Online Article Text |
id | pubmed-7165399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71653992020-04-22 AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization Spiegel, Jacob O. Durrant, Jacob D. J Cheminform Software We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from http://durrantlab.com/autogrow4. [Image: see text] Springer International Publishing 2020-04-17 /pmc/articles/PMC7165399/ /pubmed/33431021 http://dx.doi.org/10.1186/s13321-020-00429-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Software Spiegel, Jacob O. Durrant, Jacob D. AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
title | AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
title_full | AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
title_fullStr | AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
title_full_unstemmed | AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
title_short | AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
title_sort | autogrow4: an open-source genetic algorithm for de novo drug design and lead optimization |
topic | Software |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165399/ https://www.ncbi.nlm.nih.gov/pubmed/33431021 http://dx.doi.org/10.1186/s13321-020-00429-4 |
work_keys_str_mv | AT spiegeljacobo autogrow4anopensourcegeneticalgorithmfordenovodrugdesignandleadoptimization AT durrantjacobd autogrow4anopensourcegeneticalgorithmfordenovodrugdesignandleadoptimization |